Handheld imaging device using frequency domain near infrared spectroscopy to indicate within a week of starting treatment whether a breast cancer therapy is working.
One email, every morning
THE MORNING BRIEF
New clearances, funding rounds and regulatory moves for device founders. No noise, no login.
✓
You're in. The next morning brief lands in your inbox.
Unsubscribe anytime. We never sell the list.